Zabofloxacin 367mg For Five Days Versus Moxifloxacin 400mg For Seven Days In Patients With COPD Exacerbation: A Multicenter, Randomized, Double-Blind, Phase 3, Non-Inferiority Trial
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2015）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要